跳至主要内容
临床试验/EUCTR2009-010623-64-SE
EUCTR2009-010623-64-SE进行中(未招募)不适用

A clinical open, randomised study of oral iron (Duroferon®) vs. intravenous iron (Ferinject®) for iron substitution in blood donors.

Renapharma AB0 个研究点目标入组 210 人开始时间: 2009年2月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
210

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Males and females qualified as whole blood donors .
  • Fulfilled at least 5 previous whole blood donations.
  • Signed informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Anaemia not attributable to iron deficiency, e.g. other type of microcytic anaemia.
  • Iron overload.
  • Contraindications for Ferinject® or Duroferon®.
  • Contraindications for blood donations.

研究者

发起方
Renapharma AB

相似试验